Correction: WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome.
Journal: Journal Of Hematology & Oncology
Published:
Authors
Zwi Berneman, Maxime De Laere, Paul Germonpré, Manon Huizing, Yannick Willemen, Eva Lion, Hans De Reu, Jolien Van Den Bossche, Jan Van Den Brande, Pol Specenier, Sevilay Altintas, Peter Van Dam, Nathalie Cools, Griet Nijs, Barbara Stein, Kim Caluwaerts, Annemiek Snoeckx, Bart De Beeck, Kirsten Saevels, Lynn Rutsaert, Irma Vandenbosch, Gizem Oner, Martin Lammens, Pierre Van Damme, Sian Llewellyn Lacey, David Price, Yoshihiro Oka, Yusuke Oji, Haruo Sugiyama, Marie Couttenye, Ann Van De Velde, Viggo Van Tendeloo, Marc Peeters, Sébastien Anguille, Evelien L J Smits
Relevant Conditions